Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Baylin Technologies Inc T.BYL

Alternate Symbol(s):  BYLTF

Technology Communication Equipment
Baylin Technologies Inc is a diversified wireless technology management company. It focuses on the research, design, development, manufacturing, and sales of passive and active radio frequency and terrestrial microwave products and services.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (TSX:BYL)

Fundamentals Snapshot (TSX:BYL)

Current News (TSX:BYL)

Shareholder Increases Interest in Baylin Technologies

Canada NewsWire 8 days ago

Baylin Completes Private Placement Financing

Canada NewsWire 8 days ago

Baylin Announces Filing of Solicitation Materials Seeking Approval for Amendments to its Convertible Debentures

Canada NewsWire 9 days ago

Baylin Announces Voting Results from the 2023 Annual and Special Meeting of Shareholders

Canada NewsWire May 11, 2023

Baylin Announces Financial Results for the First Quarter of 2023 and its Sixth Consecutive Quarter of Positive Adjusted EBITDA

Canada NewsWire May 10, 2023

Baylin Technologies to Host First Quarter 2023 Investor Conference Call Thursday May 11, 2023 at 8 a.m. ET

Canada NewsWire May 4, 2023

Baylin Technologies Announces Receipt of a $1.75M (CAD) Purchase Order from a Major Satellite Services Provider

Canada NewsWire April 19, 2023

Baylin Technologies Announces Receipt of $537,000 Purchase Order from US Department of Defense

Canada NewsWire March 27, 2023

Baylin Announces Financial Results for Fiscal 2022

Canada NewsWire March 8, 2023
View More News ››

Opinion & Analysis (TSX:BYL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSX:BYL)

Kim Bolton

on BNN wednesdy june/7th. 
Duster340 - 2 days ago

RE:Paradigm - cantechletter.com -TAKE A PASS

What does Rosenberg think about what debenture holders will do. Will that take shares or will they agree with the 3 year extenstion ...
ciretaka198 - 8 days ago

Paradigm - cantechletter.com -TAKE A PASS

By Jayson MacLean Published on May 24, 2023 Last Updated on May 24, 2023 Filed under:   All posts...
Possibleidiot01 - 10 days ago

Now 36 pennies

dead money
Duster340 - 11 days ago

Down again

this morning. takacsy told another big whopper on his last visit to BNN, he said the turn around has begun lol, and the time before that...
Duster340 - May 12, 2023

And the recession is just starting to bite

Revenue of $25.1 million in the first quarter of 2023, a decrease of $5.9 million or 18.9% compared to the first...
Duster340 - May 11, 2023
View more Bullboard ››

BioVaxys Technology Corp

BioVaxys Technology Corp

BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine ...
View More »